Streetbeat News

Products Services

BTCUSD

GLD

NVDA

Gold has reached an all-time high, indicating strong investor conviction and momentum, while Nvidia and Bitcoin are also at all-time highs, reflecting high speculative interest. The job market remains strong, but IT jobs are weakening due to AI impacts. The European Central Bank has kept interest rates unchanged, and Japan may raise rates for the first time since 2007. Early trade money flows are positive for major tech stocks and negative for Tesla. The article suggests prudent investors are buying gold as a hedge against potential market downturns.

Portfolio Pulse from The Arora Report

March 07, 2024 | 7:44 pm

PLTR

SHLD

Palantir Technologies Inc (PLTR) secured a $178 million contract extension from the U.S. Army to develop the TITAN ground station system, powered by AI/ML technologies. Mizuho analyst Gregg Moskowitz maintained a Neutral rating on PLTR but raised the price target from $18 to $21, highlighting the company's AI expansion prospects. The deal represents a significant extension and includes software and hardware solutions. Palantir's AIPCon event is expected to showcase its AI capabilities with over 60 customers. Investors can also gain exposure to PLTR through Global X Funds Global X Defense Tech ETF (SHLD) and Tidal ETF Trust II The Meet Kevin Pricing Power ETF (PP). PLTR shares rose 3.40% to $27.05.

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 7:39 pm

BREA

CDMO

LYT

MEI

MNMD

VSCO

U.S. stocks saw gains with the S&P 500 increasing by 1.06%. Kroger (NYSE:KR) reported better-than-expected Q4 earnings but slightly missed sales estimates. Lytus Technologies (NASDAQ:LYT), Mind Medicine (NASDAQ:MNMD), and Brera Holdings (NASDAQ:BREA) saw significant stock price increases due to positive company news. Conversely, Victoria's Secret (NYSE:VSCO), Methode Electronics (NYSE:MEI), and Avid Bioservices (NASDAQ:CDMO) experienced notable declines following their earnings reports and financial updates.

Portfolio Pulse from Avi Kapoor

March 07, 2024 | 7:31 pm

AAPL

FINX

IPAY

PYPL

PayPal Holdings, Inc (NASDAQ:PYPL) has launched Tap to Pay on Apple Inc (NASDAQ:AAPL) iPhones for Venmo business profile and PayPal Zettle users in the U.S., enabling contactless payments directly on iPhones at no extra cost. This move aims to support small businesses by offering an easy, cost-effective way to accept various payment methods, enhancing their sales and financial management. The feature simplifies transactions and broadens the customer base for Venmo users. PayPal's Q4 revenue was $8.03 billion, surpassing estimates, with a 15% increase in total payment volumes year-over-year. Investors can also engage with this trend through ETFs like Amplify ETF Trust Amplify Mobile Payments ETF (NYSE:IPAY) and Global X FinTech ETF (NASDAQ:FINX).

Portfolio Pulse from Anusuya Lahiri

March 07, 2024 | 7:31 pm

PFE

The FDA has approved Pfizer Inc's leukemia drug, Besponsa, for pediatric patients aged one year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL). The approval is based on a study involving 53 pediatric patients, showing a complete remission rate of 22 out of 53 patients, with a median duration of 8.2 months. This follows the drug's initial approval for adults in August 2017. Pfizer's stock (PFE) saw a decrease of 1.03% to $26.91.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 7:25 pm

GBTC

IBIT

Solana (SOL) is trading higher by 8.1% amid overall strength in the cryptocurrency market, particularly due to a surge in Bitcoin's price to a new all-time high. The increase in Solana's price reflects the market's recognition of its potential due to its high throughput and low transaction fees. Additionally, the launch of Bitcoin spot ETFs, including BlackRock's iShares Bitcoin Trust (IBIT), has attracted significant interest, further boosting sentiment in the crypto space.

Portfolio Pulse from Henry Khederian

March 07, 2024 | 7:16 pm

RIVN

TSLA

Rivian Automotive unveiled its R2 SUV, aiming to compete with Tesla's Model Y. The R2, starting at $45,000, offers over 300 miles of range and fast acceleration. Rivian also teased the R3 and R3X models, emphasizing their unique features and the company's expansion plans, including a rapidly growing charging network. Rivian's stock rose 8.88% following the announcement.

Portfolio Pulse from Chris Katje

March 07, 2024 | 7:13 pm

ALB

Albemarle (NYSE:ALB) has seen unusual options activity, indicating a bullish sentiment among big-money investors, with a split of 66% bullish and 33% bearish. The activity includes 12 uncommon trades, with 4 puts and 8 calls, targeting a price range of $85.0 to $170.0. The largest trades observed show a mix of bullish and bearish sentiments on specific options. Albemarle, a leading lithium producer for batteries, especially in electric vehicles, has its stock price slightly down at $119.0. Analysts have issued mixed ratings, with a consensus target price of $143.4.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 6:45 pm

APVO

Aptevo Therapeutics Inc (NASDAQ:APVO) and Alligator Bioscience AB released interim Phase 1 trial data for ALG.APV-527, showing positive signs in treating solid tumors. The trial, over 50% enrolled, demonstrated the treatment's tolerability, ongoing dose escalation, and biological activity without serious side effects. APVO's stock rose 18.8% to $7.60.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 6:45 pm

RIVN

Rivian announced a delay in resuming construction at its Georgia facility to prioritize the capital-efficient launch of its R2 model in Normal, Illinois. The company also highlighted the DC fast charging capabilities of its R2 and R3 models, which can charge from 10% to 80% in less than 30 minutes. Both models are built on a new midsize vehicle platform.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 6:43 pm